Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport

Search

Close

Enter Search Terms

Sheena Wang

Sheena Wang

ID: 1b83a48f-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

ITC as a Biosimilar Battleground: Genentech Challenges Biocon’s Pertuzumab Biosimilar

Biosimilars Law Bulletin · March 4, 2026

Federal Circuit Denies Teva’s Request for En Banc Rehearing in Orange Book Patent Dispute

Biosimilars Law Bulletin · March 5, 2025

CRISPR and Agriculture

RF EMerge · February 7, 2025

Federal Circuit Stays Teva v. Amneal Ruling

Biosimilars Law Bulletin · January 27, 2025

Federal Circuit: Patent Must Claim Active Ingredient for Orange Book Listing

Biosimilars Law Bulletin · December 23, 2024

Previous

12 3 4

Next

Practice Areas

Health Care and Life Sciences

Business and Commercial

Jurisdictions

Washington, D.C.

Publishing Record

Publisher Since 2021

Total Articles 16

Most Recent March 4, 2026

Cite This Author

Sheena Wang, Rothwell Figg

LexBlog Author ID:

1b83a48f-2619-30fb-68c4

www.lexblog.com/author/swangrothwellfigg

Contact

FirmRothwell Figg

Emailswang@rothwellfigg.com

BlogsBiosimilars Law Bulletin

LinkedInView Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

Library at LexBlog

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog